Pulse Seismic Inc. Receives TSX Approval for Normal Course Issuer Bid

Stock Information for Aytu BioPharma Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Aytu BioPharma Inc.

Pulse Seismic Inc. Announces Voting Results at Shareholders' Annual Meeting
Pulse Seismic Inc. Reports Q1 2024 Results and Increases Regular Dividend
Pulse Seismic Inc. Enters Into Automatic Share Purchase Plan
Pulse Seismic Inc. Reports 2023 Financial Results and Declares Dividend
Pulse Seismic Inc. Announces $8.5 Million Seismic Data Licensing Agreement and Declares Special Dividend
Pulse Seismic Inc. Announces a $7.7 Million Seismic Data Licensing Agreement
Pulse Seismic Inc. Reports Third Quarter 2023 Results and Declares Regular Quarterly Dividend
Pulse Seismic Inc. Reports Strong Q2 2023 Results and Declares Regular Quarterly and Special Dividends

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.